ConductScience.org, home

Paper30728151

Immune-Checkpoint Blockade Opposes CD8+ T-cell Suppression in Human and Murine Cancer.

Pfannenstiel LW and 5 others. Cancer Immunol Res, 2019. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Immune-Checkpoint Blockade Opposes CD8+ T-cell Suppression in Human and Murine Cancer. Papers, record 30728151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30728151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immune-Checkpoint Blockade Opposes CD8+ T-cell Suppression in Human and Murine Cancer.
PubMed
Journal
Cancer Immunol Res
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.3
iCite
Revised in PubMed
2020-05-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pfannenstiel LWLukas W
2Diaz-Montero CMC Marcela
3Tian YFYe F
4Scharpf JJoseph
5Ko JSJennifer Shttps://orcid.org/0000-0003-0629-775X
6Gastman BRBrian R

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD8-Positive T-LymphocytesMajor topic
Hepatitis A Virus Cellular Receptor 2Major topic
Lymphocytes, Tumor-InfiltratingMajor topic
Programmed Cell Death 1 ReceptorMajor topic
Animals
Antibodies, Blocking
Cell Proliferation
Disease Models, Animal
Head and Neck Neoplasms
Humans
Immunotherapy
Interleukin-10
Interleukin-7
Ligands
Mice
Squamous Cell Carcinoma of Head and Neck
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA132796NCI NIH HHSUnited StatesR01CA132796PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121430066Anti-TIM3 antibody promotes T cell IFN-γ-mediated antitumor immunity and suppresses established tumors.Cancer Res2011https://conductscience.org/library/papers/21430066PubMed
217878327CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers.J Immunol2007https://conductscience.org/library/papers/17878327PubMed
318245489Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion.Cancer Res2008https://conductscience.org/library/papers/18245489PubMed
420525992Improved survival with ipilimumab in patients with metastatic melanoma.N Engl J Med2010https://conductscience.org/library/papers/20525992PubMed
525559415Cancer statistics, 2015.CA Cancer J Clin2015https://conductscience.org/library/papers/25559415PubMed
628331612Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response.Biomark Res2017https://conductscience.org/library/papers/28331612PubMed
725695955PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy.Mol Cancer Ther2015https://conductscience.org/library/papers/25695955PubMed
826965076Vaccines for established cancer: overcoming the challenges posed by immune evasion.Nat Rev Cancer2016https://conductscience.org/library/papers/26965076PubMed
923633484Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.Cancer Res2013https://conductscience.org/library/papers/23633484PubMed
1029163783Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients.Oncotarget2017https://conductscience.org/library/papers/29163783PubMed
1122437870The blockade of immune checkpoints in cancer immunotherapy.Nat Rev Cancer2012https://conductscience.org/library/papers/22437870PubMed
1216946036Cancer regression in patients after transfer of genetically engineered lymphocytes.Science2006https://conductscience.org/library/papers/16946036PubMed
1325624094Immunotherapy for head and neck squamous cell carcinoma.Oral Oncol2015https://conductscience.org/library/papers/25624094PubMed
1421385853Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia.Blood2011https://conductscience.org/library/papers/21385853PubMed
1522581824IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs.Cancer Res2012https://conductscience.org/library/papers/22581824PubMed
1622592956Design of a phase III clinical trial with prospective biomarker validation: SWOG S0819.Clin Cancer Res2012https://conductscience.org/library/papers/22592956PubMed
1719423728Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.Blood2009https://conductscience.org/library/papers/19423728PubMed
1818006747Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells.Science2007https://conductscience.org/library/papers/18006747PubMed
1925823918The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.Clin Ther2015https://conductscience.org/library/papers/25823918PubMed
2022658127Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.N Engl J Med2012https://conductscience.org/library/papers/22658127PubMed

See all 55 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
41961948Single-cell TCR mapping reveals spatially coordinated T cell states in head and neck cancer.Sci Immunol2026https://conductscience.org/library/papers/41961948PubMed
39025962T cell dysfunction and therapeutic intervention in cancer.Nat Immunol2024https://conductscience.org/library/papers/39025962PubMed
38296598Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity.J Immunother Cancer2024https://conductscience.org/library/papers/38296598PubMed
38023136A transcriptional evaluation of the melanoma and squamous cell carcinoma TIL compartment reveals an unexpected spectrum of exhausted and functional T cells.Front Oncol2023https://conductscience.org/library/papers/38023136PubMed
36543958Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity.Nat Immunol2023https://conductscience.org/library/papers/36543958PubMed
35954318Radiomic Signatures Associated with CD8+ Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study.Cancers (Basel)2022https://conductscience.org/library/papers/35954318PubMed
35534320A hitchhiker's guide to cancer models.Trends Biotechnol2022https://conductscience.org/library/papers/35534320PubMed
35292828Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer.Cancer Immunol Immunother2022https://conductscience.org/library/papers/35292828PubMed
35159220Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance.Cells2022https://conductscience.org/library/papers/35159220PubMed
34925340EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells.Front Immunol2021https://conductscience.org/library/papers/34925340PubMed
34900690Alphataxin, a Small-Molecule Drug That Elevates Tumor-Infiltrating CD4+ T Cells, in Combination With Anti-PD-1 Therapy, Suppresses Murine Renal Cancer and Metastasis.Front Oncol2021https://conductscience.org/library/papers/34900690PubMed
34807232A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients.J Exp Med2022https://conductscience.org/library/papers/34807232PubMed
34208113Classification of Non-Small Cell Lung Cancer's Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade.Cancers (Basel)2021https://conductscience.org/library/papers/34208113PubMed
33924671Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients.J Pers Med2021https://conductscience.org/library/papers/33924671PubMed
33802622Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis C.Cells2021https://conductscience.org/library/papers/33802622PubMed
33762351Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment.Cancer Immunol Res2021https://conductscience.org/library/papers/33762351PubMed
33654395Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.Int J Nanomedicine2021https://conductscience.org/library/papers/33654395PubMed
33627484Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity.Sci Transl Med2021https://conductscience.org/library/papers/33627484PubMed
33559853Interleukin (IL)-7 Signaling in the Tumor Microenvironment.Adv Exp Med Biol2021https://conductscience.org/library/papers/33559853PubMed
33262762Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy.Front Immunol2020https://conductscience.org/library/papers/33262762PubMed

See all 27 cited byDownload CSV of cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
HAVCR284868PubTator's text mininghttps://conductscience.org/library/genes/84868NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL153600PubTator's text mininghttps://conductscience.org/library/genes/3600NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
IL73574PubTator's text mininghttps://conductscience.org/library/genes/3574NCBI Gene
IL7R3575PubTator's text mininghttps://conductscience.org/library/genes/3575NCBI Gene
LGALS93965PubTator's text mininghttps://conductscience.org/library/genes/3965NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
PDCD1LG280380PubTator's text mininghttps://conductscience.org/library/genes/80380NCBI Gene
PTPRC5788PubTator's text mininghttps://conductscience.org/library/genes/5788NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene
TRBV20OR9-26962PubTator's text mininghttps://conductscience.org/library/genes/6962NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30728151

GET https://conductscience.org/api/papers/v1/30728151/references?page=2